Tigecycline [tigecyklin]
topical
27
- Terms
-
Tygacil
-
9-(tert-Butylglycylamido)minocycline
GAR 936
GAR-936
TBG-MINO
Tygacil
Persistent link
https://www.medvik.cz/link/D000078304
Definition
A tetracycline derivative that acts as a protein synthesis inhibitor. It is used as an antibacterial agent for the systemic treatment of complicated skin and intra-abdominal infections. It is also used for the treatment of community-acquired pneumonia.
- DUI
- D000078304 MeSH Browser
- CUI
- M0305009
- CAS
- 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-((2-((1,1-dimethylethyl)amino)acetyl)amino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-
- History note
- 2019 (1999)
- Public note
- 2019; TIGECYCLINE was indexed under MINOCYCLINE/analogs & derivatives 1999-2018
Allowable subheadings
- AD
- administration & dosage 2
- AE
- adverse effects
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BI
- biosynthesis
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology 6
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 4
- TO
- toxicity
- UR
- urine
...
Occurrences in Medvik records
D
Chemicals and Drugs